COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico.

Background: COVID-19-associated mucormycosis (CAM) has emerged as a challenging complication as the current pandemic has increased the population requiring treatment with corticosteroids. CAM has caused a massive outbreak in India, reported to be causing cases in Iran, Egypt and The Netherlands.

Objectives: To describe CAM cases occurring in a single centre in Western Mexico.